Article

Surfactant Therapy for COVID-19 Related ARDS: A Retrospective Case-Control Pilot Study.

2020-09-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>. COVID-19 causes acute respiratory distress syndrome (ARDS) and depletes the lungs of surfactant, leading to prolonged mechanical ventilation and death. The feasibility and safety of surfactant delivery in COVID-19 ARDS patients have not been established. <bold>Methods</bold>. We performed retrospective analyses of data from patients receiving off-label use of na...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ec9a6940-43dc-5042-a14d-3e128de38616
DOI: 10.21203/rs.3.rs-78815/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Surfactant Therapy for COVID-19 Related ARDS: A Retrospective Case-Control Pilot Study.DOI 10.21203/rs.3.rs-78815/v1Read

Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19.Semantic proximity Read

Altered Surfactant Protein Gene Expression in Peripheral Blood Is Associated with COVID-19 Disease SeveritySemantic proximity Read

Recent advances in understanding and treating acute respiratory distress syndromeSemantic proximity Read

Bronchoscopy in COVID19 ARDS patients on mechanical ventilation – a prospective studySemantic proximity Read

Role of Pulmonary Surfactant in Gas Exchange Mechanism and Providing Protection against Progression of any Respiratory Viral Disease like SARS-CoV-2 and Need to focus it as First Point of Medication for all Respiratory DiseasesSemantic proximity Read

Effect of Intravenous N-acetylcysteine on Prevention of Mechanical Ventilation and Mortality among COVID-19 Patients: A Meta-AnalysisSemantic proximity Read

Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infectionsSemantic proximity Read

Effectiveness and safety of non-invasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure: a single center, non-ICU setting experience.Semantic proximity Read

The surfactant system protects both fetus and newborn.Semantic proximity Read

Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.Semantic proximity Read

HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity Read

Progressive respiratory failure in a term neonate with ABCA3 surfactant deficiency: Beyond the common causes of respiratory distress.Semantic proximity Read